Project Grant R01EY033816
Award Date
9/1/24
Completion Date
4/30/29
Dollars Obligated
$1.1M
Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Stanford, CA 94305, USA
Similar Awards
This $526,841 Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), supports research to investigate the role of cyclic guanosine monophosphate (cGMP) signaling in glaucomatous neurodegeneration. The primary objectives are to determine how disrupted cGMP signaling affects retinal astrocyte-vascular networks, leading to retinal ganglion cell (RGC) metabolic stress and axon degeneration in glaucoma. The research will discern age- versus...
This federal Project Grant award from the National Eye Institute (NEI), under the CFDA 93.867 Vision Research Program, provides funding of $679,159 from May 1, 2025 to April 30, 2029 to The Schepens Eye Research Institute, Inc. to conduct research on in vivo epigenetic reprogramming of retinal ganglion cells in aging mice with glaucoma. The key objectives of this research project are to: (1) investigate the combined effects of aging and elevated intraocular pressure on the development of...
This Project Grant award from the National Eye Institute (NEI), part of the Vision Research federal grant program (CFDA 93.867), will provide $753,959 to Baylor College of Medicine over the period of June 1, 2024 to May 31, 2029. The project aims to investigate the mechanistic connections between retinal ganglion cell (RGC) activity, resilience, and axon regeneration following traumatic injuries and optic neuropathies like glaucoma. The research will employ cutting-edge approaches to dissect the...
The National Eye Institute (NEI) awarded a $387,428 Project Grant under its Vision Research program (CFDA 93.867) to investigate mechanisms underlying optic nerve sensitivity to glaucomatous damage. The award, with a project period from March 1, 2025 to February 28, 2030, will support research conducted by The Research Foundation for the State University of New York, Upstate Medical Center. The research aims to: 1) Determine how optic nerve head astrocytes integrate transient biomechanical...
The National Eye Institute (NEI) awarded a $1,666,746 Project Grant (CFDA 93.867 - Vision Research) to The Leland Stanford Junior University to investigate how the expression of activated forms of calcium/calmodulin-dependent protein kinase II (CaMKII) can provide neuroprotection for retinal ganglion cells, while also potentially suppressing axon regeneration. The research project aims to derive strategies that promote retinal ganglion cell survival without preventing axon regeneration, which is...
This $184,238 Project Grant awarded by the National Eye Institute (CFDA 93.867 Vision Research) supports research to evaluate the functional impact of retinal ganglion cell (RGC) loss during the progression of neurofibromatosis type-1 (NF1)-associated optic glioma, and to examine whether transplanted RGCs can integrate with the remaining retinal circuitry. The grant recipient, The Leland Stanford Junior University, will conduct this work in the laboratory of Dr. Jeffrey Goldberg at the Byers Eye...
This federal Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) is focused on investigating the role of neural activity in improving retinal ganglion cell (RGC) replacement therapies for glaucoma. The $132,597 grant aims to establish a model for manipulating host RGC neural activity to distinguish donor RGC activity and quantify functional integration with existing visual neural circuits. The research will explore how inhibiting host...
This Project Grant award from the National Eye Institute (NEI), under the Federal Grant Program for Vision Research (CFDA 93.867), provides $234,000.00 in funding from February 1, 2025 to January 31, 2027. The funding supports research to explore the use of senolytic treatments and stem cell transplantation to restore intraocular pressure (IOP) homeostasis in glaucoma patients. The research aims to determine if removing senescent trabecular meshwork cells and/or transplanting stem cells can help...
This Project Grant award from the National Eye Institute (NEI), under CFDA 93.867 (Vision Research), provides $447,479 in funding to the Georgia Tech Research Corporation to investigate the molecular mechanisms underlying trabecular meshwork cell loss in glaucoma. The research aims to leverage a yeast model system to identify gene products and pathways contributing to cytotoxicity caused by misfolded mutant myocilin, a leading genetic cause of glaucoma. The expected outcomes include new...
This National Eye Institute (NEI) Project Grant award under CFDA Program 93.867 (Vision Research) provides $249,000.00 to the Leland Stanford Junior University to study the molecular mechanisms regulating the expression of phototransduction genes in mammalian rod photoreceptors. The research aims to elucidate how transcriptional elongation and mRNA processing, including splicing, are coupled to enhance the efficiency and accuracy of gene expression for vision-critical pathways. Genetic,...